These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 2141221)
21. Myocardial viability assessment with dynamic low-dose iodine-123-iodophenylpentadecanoic acid metabolic imaging: comparison with myocardial biopsy and reinjection SPECT thallium after myocardial infarction. Murray GL; Schad NC; Magill HL; Vander Zwaag R J Nucl Med; 1994 Apr; 35(4 Suppl):43S-48S. PubMed ID: 8151413 [TBL] [Abstract][Full Text] [Related]
22. [Value of 123I-BMIPP scintigraphy in patients with ischemic heart disease: comparison with exercise 201Tl SPECT]. Taki J; Nakajima K; Matsunari I; Bunko H; Takada S; Muramori A; Tonami N; Hisada K Kaku Igaku; 1995 Apr; 32(4):353-8. PubMed ID: 7776541 [TBL] [Abstract][Full Text] [Related]
23. [Dipyridamole-echocardiography and thallium exercise myocardial scintigraphy in the diagnosis of obstructive coronary or microvascular disease in hypertensive patients with left ventricular hypertrophy and angina]. Astarita C; Nicolai E; Liguori E; Gambardella S; Rumolo S; Maresca FS G Ital Cardiol; 1998 Sep; 28(9):996-1004. PubMed ID: 9788038 [TBL] [Abstract][Full Text] [Related]
24. Abnormal myocardial free fatty acid utilization deteriorates with morphological changes in the hypertensive heart. Nakayama H; Morozumi T; Nanto S; Shimonagata T; Ohara T; Takano Y; Kotani J; Watanabe T; Fujita M; Nishio M; Kusuoka H; Hori M; Nagata S Jpn Circ J; 2001 Sep; 65(9):783-7. PubMed ID: 11548876 [TBL] [Abstract][Full Text] [Related]
25. 123I-IPPA SPECT for the prediction of enhanced left ventricular function after coronary bypass graft surgery. Multicenter IPPA Viability Trial Investigators. 123I-iodophenylpentadecanoic acid. Verani MS; Taillefer R; Iskandrian AE; Mahmarian JJ; He ZX; Orlandi C J Nucl Med; 2000 Aug; 41(8):1299-307. PubMed ID: 10945518 [TBL] [Abstract][Full Text] [Related]
26. Fasting and nonfasting iodine-123-idophenylpentadecanoic acid myocardial SPECT imaging in coronary artery disease. Heller GV; Iskandrian AE; Orlandi C; Ahlberg AW; Heo J; Mann A; White MP; Gagnon A; Taillefer R J Nucl Med; 1998 Dec; 39(12):2019-22. PubMed ID: 9867134 [TBL] [Abstract][Full Text] [Related]
27. [Myocardial sympathetic activity and characteristics in hypertrophic cardiomyopathy: comparison with hypertensive hypertrophy]. Narita M; Kurihara T J Cardiol; 1996 Mar; 27(3):133-41. PubMed ID: 8865685 [TBL] [Abstract][Full Text] [Related]
28. [Application of straight chain fatty acid analog IPPA [omega-(p-iodophenyl)-pentadecanoic acid] for myocardial imaging--using acute myocardial infarction model]. Kawamura Y; Yamazaki J; Okuzumi I; Uchi T; Muto T; Nakano H; Wakakura M; Okamoto K; Hosoi H; Morishita T Kaku Igaku; 1989 Oct; 26(10):1295-301. PubMed ID: 2585843 [TBL] [Abstract][Full Text] [Related]
29. Clinical evaluation of 123I-labeled p-phenylpentadecanoic acid (p-IPPA) for myocardial scintigraphy. Dudczak R; Schmoliner R; Kletter K; Frischauf H; Angelberger P J Nucl Med Allied Sci; 1983; 27(4):267-79. PubMed ID: 6674428 [No Abstract] [Full Text] [Related]
30. Combined thallium-201 and dynamic iodine-123 iodophenylpentadecanoic acid single-photon emission computed tomography in patients after acute myocardial infarction with effective reperfusion. Richter WS; Beckmann S; Cordes M; Schuppenhauer T; Schartl M; Munz DL Clin Cardiol; 2000 Dec; 23(12):902-8. PubMed ID: 11129676 [TBL] [Abstract][Full Text] [Related]
31. Identification of viable myocardium in patients with chronic coronary artery disease and left ventricular dysfunction. Comparison of thallium scintigraphy with reinjection and PET imaging with 18F-fluorodeoxyglucose. Bonow RO; Dilsizian V; Cuocolo A; Bacharach SL Circulation; 1991 Jan; 83(1):26-37. PubMed ID: 1984883 [TBL] [Abstract][Full Text] [Related]
32. [Washout rate in hypertrophic cardiomyopathy assessed by exercise myocardial scintigraphy]. Genda A; Igarashi Y; Mizuno S; Sugihara N; Kita Y; Suematsu T; Shimizu M; Takeda R; Bunko H; Hisada K J Cardiogr; 1986 Dec; 16(4):893-905. PubMed ID: 3429906 [TBL] [Abstract][Full Text] [Related]
33. 15-(ortho-123I-phenyl)-pentadecanoic acid, a new myocardial imaging agent for clinical use. Antar MA; Spohr G; Herzog HH; Kaiser KP; Notohamiprodjo G; Vester E; Schwartzkopf B; Lösse B; Machulla HJ; Shreeve WW Nucl Med Commun; 1986 Sep; 7(9):683-96. PubMed ID: 3774263 [TBL] [Abstract][Full Text] [Related]
34. [Myocardial scintigraphy with Tc-99m-teboroxime: its feasibility and the evaluation of its diagnostic reliability. A comparison with thallium-201 and coronary angiography]. Bisi G; Sciagrà R; Santoro GM; Cerisano G; Vella A; Zerauschek F; Fazzini PF G Ital Cardiol; 1992 Jul; 22(7):795-805. PubMed ID: 1473653 [TBL] [Abstract][Full Text] [Related]
35. Preliminary report of an ongoing phase I/II dose range, safety and efficacy study of iodine-123-phenylpentadecanoic acid for the identification of viable myocardium. Hansen CL J Nucl Med; 1994 Apr; 35(4 Suppl):38S-42S. PubMed ID: 8151411 [TBL] [Abstract][Full Text] [Related]